Skip to main content
Livermore
Livermore
ZHEN

Glenmede Trust Co NA

SEC CIK
0000314949
Latest filing
Aug 10, 2026

BSX holding history

Boston Scientific Corp in every 13F filed by Glenmede Trust Co NA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BSX overviewAll 13F holders of BSXFull Q2 2026 holdings

Shares (Q2 2026)
102,235
Value
$4.36M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of BSX by Glenmede Trust Co NA, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026102,235$4.36M<0.1%−19,333−15.9%ReducedHolders
Q1 2026121,568$7.63M<0.1%+13,572+12.6%AddedHolders
Q4 2025107,996$10.3M<0.1%–No prior filingHolders
Q2 2025––––Not filedHolders
Q1 202519,819$2.00M<0.1%+1,874+10.4%AddedHolders
Q4 202417,945$1.60M<0.1%−2,518−12.3%ReducedHolders
Q3 202420,463$1.71M<0.1%+3,261+19.0%AddedHolders
Q2 202417,202$1.32M<0.1%+1,062+6.6%AddedHolders
Q1 202416,140$1.11M<0.1%+1,131+7.5%AddedHolders
Q4 202315,009$867.7K<0.1%+4,567+43.7%AddedHolders
Q3 202310,442$551.3K<0.1%+1,123+12.1%AddedHolders
Q2 20239,319$466.2K<0.1%00.0%UnchangedHolders
Q1 20239,319$466.2K<0.1%+923+11.0%AddedHolders
Q4 20228,396$388.5K<0.1%−659−7.3%ReducedHolders
Q3 20229,055$349.0K<0.1%+9,055NewHolders
Q2 20220$00.0%−6,199−100.0%Sold outHolders
Q1 20226,199$274.0K<0.1%−978−13.6%ReducedHolders
Q4 20217,177$304.0K<0.1%+792+12.4%AddedHolders
Q3 20216,385$276.0K<0.1%+31+0.5%AddedHolders
Q2 20216,354$270.0K<0.1%−366−5.4%ReducedHolders
Q1 20216,720$259.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.